Drug Database
Back to search

Iceland· IS-EU/1/00/140/001

Visudyne

A verteporfin product containing verteporfinum inn, registered in Iceland by CHEPLAPHARM Arzneimittel GmbH. The same ATC class is registered in 15 of our 19 countries.

ATC S01LA01

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedVisudyneATCS01LA01REGISTER NO.IS-EU/1/00/140/001PACKS LISTED2CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about verteporfinum innAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Verteporfin is registered in 15 of 19 countries.

Countries holding a registration under ATC S01LA01 (verteporfin), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 9 of them publish a price we can compare per daily dose
Search verteporfin products by name

Verteporfin · ATC S01LA01

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Verteporfinum INN
Manufacturer
CHEPLAPHARM Arzneimittel GmbH
Country
Iceland (IS)
ATC code
S01LA01
ATC class
Verteporfin
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 2

2 priced
  • ean
    964728
    1 hgl x1 pakki
    ISK 526306
  • ean
    998867
    1 hgl x1 pakki
    ISK 372793

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

166 interactions on record for verteporfin.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check verteporfin against other medicinesHow interaction checks work

Verteporfin · interactions on record

166 records

  • 1 severe
  • 144 moderate
  • 2 minor
  • 19 info

Most severe, free to view

  • Aminolevulinic acidL01XD04severe
  • TetracyclineA01AB13moderate
  • DoxycyclineA01AB22moderate
  • MinocyclineA01AB23moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Verteporfin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All verteporfin products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Liechtenstein · Visudyne
  • Norway · Visudyne

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5c9b4597-9041-43f5-846a-e23b948c52e2
GET /v1/drugs/5c9b4597-9041-43f5-846a-e23b948c52e2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Innrennslisstofn, lausn",
  "source": "lyfjastofnun",
  "atc_raw": "S01LA01",
  "marketed": false,
  "strength": "15 mg",
  "ma_number": "EU/1/00/140/001",
  "substance": "Verteporfinum INN",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
  "ma_issued_serial": "36801"
}
API referenceMCP serverPlans

See everything about verteporfin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console